EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Atypical inflammatory bowel disease and multi‐system inflammation expand the phenotype of inhibitor of nuclear factor kappa B kinase subunit beta gain‐of‐function variants

James J. Ashton, Mercedes Selby, Zachary Green, Lynn K. Win, Fernando Vázquez López, Alex Z. Kadhim, Iman Nazari, Guo Cheng, Bhumita Vadgama, Anthony P. Williams, Alexander Ross, R Mark Beattie und 2 weitere

Journal of Pediatric Gastroenterology and Nutrition · 18.11.2026

DOI: 10.1002/jpn3.70689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 18.11.2026. Verfasst von James J. Ashton und 13 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, Children with Chrohn's and Colitis.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Gain‐of‐function (GoF) variants in the inhibitor of nuclear factor kappa‐B kinase subunit beta (IKK2) protein, encoded by inhibitor of nuclear factor kappa B kinase subunit beta (IKBKB) , have previously been reported to cause autoinflammation with a progressive immunodeficiency. Genetic defects have not previously been described in inflammatory bowel disease (IBD), although disruption of highly interacting proteins, such as IKBKG and RELA , are known causes of monogenic IBD.

Methods

Using whole exome sequencing data, we screened a cohort of over 1250 adult and paediatric onset patients with IBD for deleterious variants (minor allele frequency < 0.0005, Combined Annotation Dependent Depletion [CADD] > 15) in IKBKB . We retrieved in‐depth phenotypic data and performed peripheral blood mononuclear cell CD25/CD70 stimulation validation in patients with apparent IKBKB GoF variants.

Results

We identified 11 patients with potentially pathogenic variants. Correlation with clinical and immunophenotypic data prioritised a rare, potential gain‐of‐function, variant in a patient and his affected parent, c.522T>G, p Asp174Glu. The proband had multi‐system inflammation and severe atypical inflammatory bowel disease with rectal stricturing. We demonstrated impaired CD25/CD70 T‐ and B‐cell responses in the patient, characteristic of the IKBKB defect, alongside hallmark immunological manifestations of reduced natural killer and B‐cell numbers, and perturbed immunoglobulin titres. Treatment with a selective Janus kinase (JAK1)‐inhibitor resulted in rapid clinical and biochemical improvement.

Conclusions

This study expands the phenotypic manifestation of IKBKB GoF variants to include IBD and demonstrates a biologically plausible targeted treatment. Further functional work is required to elucidate the precise mechanism of bowel inflammation and identify additional patients.

Förderung

  • National Institute for Health and Care Research
  • Children with Chrohn's and Colitis

Zitieren

APA

Ashton, J. J., Selby, M., Green, Z., Win, L. K., López, F. V., Kadhim, A. Z., Nazari, I., Cheng, G., Vadgama, B., Williams, A. P., Ross, A., Beattie, R. M., Gilmour, K., & Ennis, S. (2026). Atypical inflammatory bowel disease and multi‐system inflammation expand the phenotype of inhibitor of nuclear factor kappa B kinase subunit beta gain‐of‐function variants. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70689

Vancouver

Ashton JJ, Selby M, Green Z, Win LK, López FV, Kadhim AZ, et al. Atypical inflammatory bowel disease and multi‐system inflammation expand the phenotype of inhibitor of nuclear factor kappa B kinase subunit beta gain‐of‐function variants. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70689

BibTeX
@article{Ashton2026,
  author = {Ashton, James J. and Selby, Mercedes and Green, Zachary and Win, Lynn K. and López, Fernando Vázquez and Kadhim, Alex Z. and Nazari, Iman and Cheng, Guo and Vadgama, Bhumita and Williams, Anthony P. and Ross, Alexander and Beattie, R Mark and Gilmour, Kimberly and Ennis, Sarah},
  title = {Atypical inflammatory bowel disease and multi‐system inflammation expand the phenotype of inhibitor of nuclear factor kappa B kinase subunit beta gain‐of‐function variants},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2026},
  doi = {10.1002/jpn3.70689}
}
Kostenlos starten →